Κ.S. Vitols

571 total citations
32 papers, 480 citations indexed

About

Κ.S. Vitols is a scholar working on Molecular Biology, Rheumatology and Organic Chemistry. According to data from OpenAlex, Κ.S. Vitols has authored 32 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Rheumatology and 8 papers in Organic Chemistry. Recurrent topics in Κ.S. Vitols's work include Folate and B Vitamins Research (15 papers), Biochemical and Molecular Research (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Κ.S. Vitols is often cited by papers focused on Folate and B Vitamins Research (15 papers), Biochemical and Molecular Research (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Κ.S. Vitols collaborates with scholars based in United States, Switzerland and Germany. Κ.S. Vitols's co-authors include F.M. Huennekens, Gary B. Henderson, K. G. Scrimgeour, M.R. Suresh, Jianguo Fan, Katsuhiko Fujii, Laura E. Pope, R. Calvert, S. R. S. Rangan and D.W. Jacobsen and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

Κ.S. Vitols

32 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Κ.S. Vitols United States 15 276 156 98 71 63 32 480
Paul L. Chello United States 17 395 1.4× 154 1.0× 140 1.4× 85 1.2× 148 2.3× 30 695
Jack R. Uren United States 13 239 0.9× 69 0.4× 66 0.7× 65 0.9× 68 1.1× 18 468
Richard Leary United States 10 301 1.1× 47 0.3× 105 1.1× 44 0.6× 71 1.1× 12 520
Joyce K. Randolph United States 13 415 1.5× 36 0.2× 319 3.3× 66 0.9× 69 1.1× 23 781
Edward M. Zevely United States 16 329 1.2× 338 2.2× 144 1.5× 48 0.7× 175 2.8× 22 710
Małgorzata Balińska Poland 11 272 1.0× 133 0.9× 66 0.7× 61 0.9× 89 1.4× 33 472
Jean‐Claude Maurizis France 14 209 0.8× 77 0.5× 71 0.7× 92 1.3× 16 0.3× 33 484
P. Hambleton Canada 6 185 0.7× 52 0.3× 37 0.4× 48 0.7× 22 0.3× 8 360
Sylvia J. Kerr United States 13 684 2.5× 212 1.4× 48 0.5× 20 0.3× 19 0.3× 31 880
Bettina Schmidt Germany 13 466 1.7× 36 0.2× 73 0.7× 58 0.8× 16 0.3× 18 744

Countries citing papers authored by Κ.S. Vitols

Since Specialization
Citations

This map shows the geographic impact of Κ.S. Vitols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Κ.S. Vitols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Κ.S. Vitols more than expected).

Fields of papers citing papers by Κ.S. Vitols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Κ.S. Vitols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Κ.S. Vitols. The network helps show where Κ.S. Vitols may publish in the future.

Co-authorship network of co-authors of Κ.S. Vitols

This figure shows the co-authorship network connecting the top 25 collaborators of Κ.S. Vitols. A scholar is included among the top collaborators of Κ.S. Vitols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Κ.S. Vitols. Κ.S. Vitols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitols, Κ.S., et al.. (1992). Activation of methotrexate-.alpha.-alanine by carboxypeptidase A monoclonal antibody conjugate. Biochemistry. 31(3). 891–897. 28 indexed citations
2.
Huennekens, F.M., Κ.S. Vitols, Laura E. Pope, & Jun‐Yu Fan. (1992). Membrane Transport of Folate Compounds. Journal of Nutritional Science and Vitaminology. 38(Special). 52–57. 8 indexed citations
3.
Fan, Jianguo, Κ.S. Vitols, & F.M. Huennekens. (1992). Multiple folate transport systems in L1210 cells. Advances in Enzyme Regulation. 32. 3–15. 14 indexed citations
4.
Fan, Jian‐Gao, L.E. Pope, Κ.S. Vitols, & F.M. Huennekens. (1991). Affinity labeling of folate transport proteins with the N-hydroxysuccinimide ester of .gamma.-isomer of fluorescein-methotrexate. Biochemistry. 30(18). 4573–4580. 16 indexed citations
5.
Hänseler, Edgar, et al.. (1991). Construction and chemotherapeutic potential of carboxypeptidase-A/monoclonal antibody conjugate. Advances in Enzyme Regulation. 31. 3–12. 14 indexed citations
6.
Vitols, Κ.S., et al.. (1991). Activation of Methotrexate Prodrugs by Enzyme/Monoclonal Antibody Conjugates. Pteridines. 3(1-2). 125–126. 4 indexed citations
7.
Fan, Jianguo, Κ.S. Vitols, & F.M. Huennekens. (1991). Biotin derivatives of methotrexate and folate. Synthesis and utilization for affinity purification of two membrane-associated folate transporters from L1210 cells. Journal of Biological Chemistry. 266(23). 14862–14865. 29 indexed citations
8.
Vitols, Κ.S., et al.. (1990). Occurrence and significance of diastereomers of methotrexate .alpha.-peptides. Biochemistry. 29(46). 10540–10545. 10 indexed citations
9.
Fan, Junyu, Laura E. Pope, Κ.S. Vitols, & F.M. Huennekens. (1990). Visualization of folate transport proteins by covalent labeling with fluorescein methotrexate. Advances in Enzyme Regulation. 30. IN1–12. 4 indexed citations
10.
Vitols, Κ.S., et al.. (1989). Selective Cytotoxicity of Carboxypeptidase-activated Methotrexate ex-Peptides. Pteridines. 1(1). 65–69. 7 indexed citations
11.
Pope, Laura E., et al.. (1989). Visualization of membrane-associated folate transport proteins. Advances in Enzyme Regulation. 28. 3–11. 3 indexed citations
12.
Huennekens, F.M., et al.. (1988). Overview: Rational Basis for Development of Fluoropyrimidine/5-Formyltetrahydrofolate Combination Chemotherapy. Advances in experimental medicine and biology. 244. 1–11. 2 indexed citations
13.
Vitols, Κ.S., et al.. (1988). Chemotherapeutic potential of methotrexate peptides. Advances in Enzyme Regulation. 27. xvii–xviii. 5 indexed citations
14.
Vitols, Κ.S., et al.. (1987). Platinum-folate compounds: synthesis, properties and biological activity. Advances in Enzyme Regulation. 26. 17–27. 14 indexed citations
15.
Pope, Laura E., S A Minskoff, Cheng‐Ming Chang, Κ.S. Vitols, & F.M. Huennekens. (1987). Antibody for detection and quantitation of membrane-associated folate-binding protein from Lactobacillus casei. Analytical Biochemistry. 161(2). 533–542. 1 indexed citations
16.
Huennekens, F.M., et al.. (1987). Folic acid metabolism and its disruption by pharmacologic agents.. PubMed. 1–8. 25 indexed citations
17.
Fujii, Katsuhiko, T. Nagasaki, Κ.S. Vitols, & F.M. Huennekens. (1983). Polyglutamylation as a Factor in the Trapping of 5-Methyltetrahydrofolate by Cobalamin-Deficient L1210 Cells. Advances in experimental medicine and biology. 163. 375–397. 6 indexed citations
18.
Huennekens, F.M., Κ.S. Vitols, & Gary B. Henderson. (1979). Transport of Folate Compounds in Bacterial and Mammalian Cells. Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects. 47. 313–346. 39 indexed citations
19.
Huennekens, F.M., et al.. (1976). B12 — Dependent methionine synthetase as a potential target for cancer chemotherapy. Advances in Enzyme Regulation. 14. 187–205. 26 indexed citations
20.
Scrimgeour, K. G. & Κ.S. Vitols. (1966). The Reduction of Folate by Borohydride*. Biochemistry. 5(4). 1438–1443. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026